408 related articles for article (PubMed ID: 33184108)
1. Replication Gaps Underlie BRCA Deficiency and Therapy Response.
Panzarino NJ; Krais JJ; Cong K; Peng M; Mosqueda M; Nayak SU; Bond SM; Calvo JA; Doshi MB; Bere M; Ou J; Deng B; Zhu LJ; Johnson N; Cantor SB
Cancer Res; 2021 Mar; 81(5):1388-1397. PubMed ID: 33184108
[TBL] [Abstract][Full Text] [Related]
2. Revisiting the BRCA-pathway through the lens of replication gap suppression: "Gaps determine therapy response in BRCA mutant cancer".
Cantor SB
DNA Repair (Amst); 2021 Nov; 107():103209. PubMed ID: 34419699
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 controls homologous recombination at Tus/Ter-stalled mammalian replication forks.
Willis NA; Chandramouly G; Huang B; Kwok A; Follonier C; Deng C; Scully R
Nature; 2014 Jun; 510(7506):556-9. PubMed ID: 24776801
[TBL] [Abstract][Full Text] [Related]
4. Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.
Cong K; Peng M; Kousholt AN; Lee WTC; Lee S; Nayak S; Krais J; VanderVere-Carozza PS; Pawelczak KS; Calvo J; Panzarino NJ; Turchi JJ; Johnson N; Jonkers J; Rothenberg E; Cantor SB
Mol Cell; 2021 Aug; 81(15):3128-3144.e7. PubMed ID: 34216544
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
6. Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks.
Nagaraju G; Scully R
DNA Repair (Amst); 2007 Jul; 6(7):1018-31. PubMed ID: 17379580
[TBL] [Abstract][Full Text] [Related]
7. The
Simoneau A; Xiong R; Zou L
Genes Dev; 2021 Sep; 35(17-18):1271-1289. PubMed ID: 34385259
[TBL] [Abstract][Full Text] [Related]
8. Exploiting replication gaps for cancer therapy.
Cong K; Cantor SB
Mol Cell; 2022 Jul; 82(13):2363-2369. PubMed ID: 35568026
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication.
Fridlich R; Annamalai D; Roy R; Bernheim G; Powell SN
DNA Repair (Amst); 2015 Jun; 30():11-20. PubMed ID: 25836596
[TBL] [Abstract][Full Text] [Related]
10. Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy.
Vollebergh MA; Lips EH; Nederlof PM; Wessels LF; Wesseling J; Vd Vijver MJ; de Vries EG; van Tinteren H; Jonkers J; Hauptmann M; Rodenhuis S; Linn SC
Breast Cancer Res; 2014 May; 16(3):R47. PubMed ID: 24887359
[TBL] [Abstract][Full Text] [Related]
11. Replication gap suppression depends on the double-strand DNA binding activity of BRCA2.
Vugic D; Dumoulin I; Martin C; Minello A; Alvaro-Aranda L; Gomez-Escudero J; Chaaban R; Lebdy R; von Nicolai C; Boucherit V; Ribeyre C; Constantinou A; Carreira A
Nat Commun; 2023 Jan; 14(1):446. PubMed ID: 36707518
[TBL] [Abstract][Full Text] [Related]
12. Temporally distinct post-replicative repair mechanisms fill PRIMPOL-dependent ssDNA gaps in human cells.
Tirman S; Quinet A; Wood M; Meroni A; Cybulla E; Jackson J; Pegoraro S; Simoneau A; Zou L; Vindigni A
Mol Cell; 2021 Oct; 81(19):4026-4040.e8. PubMed ID: 34624216
[TBL] [Abstract][Full Text] [Related]
13. Replication fork stability confers chemoresistance in BRCA-deficient cells.
Ray Chaudhuri A; Callen E; Ding X; Gogola E; Duarte AA; Lee JE; Wong N; Lafarga V; Calvo JA; Panzarino NJ; John S; Day A; Crespo AV; Shen B; Starnes LM; de Ruiter JR; Daniel JA; Konstantinopoulos PA; Cortez D; Cantor SB; Fernandez-Capetillo O; Ge K; Jonkers J; Rottenberg S; Sharan SK; Nussenzweig A
Nature; 2016 Jul; 535(7612):382-7. PubMed ID: 27443740
[TBL] [Abstract][Full Text] [Related]
14. CtIP-Mediated Fork Protection Synergizes with BRCA1 to Suppress Genomic Instability upon DNA Replication Stress.
Przetocka S; Porro A; Bolck HA; Walker C; Lezaja A; Trenner A; von Aesch C; Himmels SF; D'Andrea AD; Ceccaldi R; Altmeyer M; Sartori AA
Mol Cell; 2018 Nov; 72(3):568-582.e6. PubMed ID: 30344097
[TBL] [Abstract][Full Text] [Related]
15. Loss of MED12 activates the TGFβ pathway to promote chemoresistance and replication fork stability in BRCA-deficient cells.
Jackson LM; Dhoonmoon A; Hale A; Dennis KA; Schleicher EM; Nicolae CM; Moldovan GL
Nucleic Acids Res; 2021 Dec; 49(22):12855-12869. PubMed ID: 34871431
[TBL] [Abstract][Full Text] [Related]
16. The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings.
Helleday T
Mol Oncol; 2011 Aug; 5(4):387-93. PubMed ID: 21821475
[TBL] [Abstract][Full Text] [Related]
17. Differential chemotherapeutic sensitivity for breast tumors with "BRCAness": a review.
Chalasani P; Livingston R
Oncologist; 2013; 18(8):909-16. PubMed ID: 23881989
[TBL] [Abstract][Full Text] [Related]
18. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging.
Turan V; Oktay K
Hum Reprod Update; 2020 Jan; 26(1):43-57. PubMed ID: 31822904
[TBL] [Abstract][Full Text] [Related]
19. Shaping the BRCAness mutational landscape by alternative double-strand break repair, replication stress and mitotic aberrancies.
Stok C; Kok YP; van den Tempel N; van Vugt MATM
Nucleic Acids Res; 2021 May; 49(8):4239-4257. PubMed ID: 33744950
[TBL] [Abstract][Full Text] [Related]
20. Error-prone repair of stalled replication forks drives mutagenesis and loss of heterozygosity in haploinsufficient BRCA1 cells.
Deshpande M; Paniza T; Jalloul N; Nanjangud G; Twarowski J; Koren A; Zaninovic N; Zhan Q; Chadalavada K; Malkova A; Khiabanian H; Madireddy A; Rosenwaks Z; Gerhardt J
Mol Cell; 2022 Oct; 82(20):3781-3793.e7. PubMed ID: 36099913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
